Multilingual Language Sample Analyzer

School Beta • Clinician Decision-Support Software • v1.18

School Beta — Clinician Decision-Support Software. This software assists qualified speech-language pathologists with language-sample calculation, organization, and clinical review. It is not a standardized or independently validated diagnostic assessment and must not be used as the sole basis for diagnosis, special education eligibility, or educational programming.

School Beta Use Acknowledgment

Complete these acknowledgments before analyzing a case. They reset when the page is reloaded; the analyzer does not store your acknowledgment or sample content.

School Beta Terms of Use

Intended users. This beta is intended for qualified speech-language pathologists and appropriately supervised trainees/assistants acting within their scope and local policies.

Clinical responsibility. The software provides calculations, candidate findings, research context, organizational support, and draft language. The evaluating clinician remains responsible for transcript segmentation, coding, interpretation, diagnosis, eligibility recommendations, and final report language.

Not a test. The software is not a standardized assessment, does not generate a diagnostic probability, and must not be used as a sole criterion for disability identification, eligibility, placement, or programming.

Data restrictions. Do not enter identifiable student, patient, family, staff, or school information. Do not use the beta as a patient record, educational record repository, or clinical documentation system.

School use. Users are responsible for confirming that use complies with their district/LEA policies and applicable laws, including requirements governing evaluation procedures and student privacy.

Research references. Published research is provided as clinical context only. Study populations, methods, and eligibility conditions must be reviewed before applying a research comparison to an individual student.

Beta limitations. Automated detection can miss patterns or produce false positives. Outputs may change during beta development. Clinicians must independently review every output used in an evaluation.

No legal advice. These beta terms are operational safeguards, not legal advice or a substitute for attorney-reviewed commercial terms.

Privacy Notice — School Beta

Local browser processing. The analyzer code processes entered profile information and language samples in browser memory. The analyzer does not include a backend database, authentication system, cookies, local/session storage, IndexedDB, or application-level analytics.

No intentional sample transmission. The analyzer code does not include fetch/XHR/WebSocket/sendBeacon calls that transmit language-sample content. Sample text is not intentionally sent to Hola Clinic by the analyzer. Copy and Print actions occur only when the user initiates them.

Hosting caveat. Wix, the web browser, network providers, and site-level analytics/security systems may create ordinary technical logs independently of the analyzer. For this reason, identifiable student information is prohibited even though the analyzer itself is designed for local browser-memory processing.

Retention. The analyzer does not intentionally persist entered sample content after the page is closed or reloaded. Users are responsible for any report text they copy, print, download, or place into an educational or clinical record.

External links. DOI/reference links leave the app and open third-party research websites. Do not include student data in external searches or URLs.

Privacy audit. v1.18 was statically audited on October 8, 2026 for application-level network/storage calls after the citation, disclosure, and methodology update.

Analysis locked: complete all four acknowledgments.

1. Language profile

2. Language samples

De-identification required: Replace names and identifying references with neutral placeholders (for example, [CHILD], [PEER], [TEACHER], [SCHOOL]). Do not paste report headers, demographics, IEP identifiers, DOBs, contact information, or school names into the sample boxes.
Privacy scan will run before analysis. This automated screen is limited and does not replace clinician de-identification.

About, Citation & Disclosures

The Multilingual Language Sample Analyzer is clinical-beta clinician decision-support software designed to help qualified speech-language pathologists organize, calculate, review, and document multilingual language-sample findings. It does not independently diagnose a communication disorder or determine eligibility for services.

How to Cite This Tool

Suggested APA 7 citation

Arellano, K. (2026). Multilingual Language Sample Analyzer (Version 1.18) [Computer software, clinical beta]. Hola Clinic Bilingual Speech Language Pathology Inc. https://www.holaclinic.com/multilingual-lsa

In-text citation: (Arellano, 2026)

Cite the software when documenting that the analyzer was used. Cite the original research article(s) separately when making a research-based statement about a specific measure, threshold, or interpretation.

Development & Technology Disclosure

The Multilingual Language Sample Analyzer was conceptualized and clinically directed by Kelly Arellano, M.S., CCC-SLP. Generative artificial intelligence tools, including OpenAI ChatGPT, were used during development to assist with software coding, interface development, drafting, technical review, and quality-assurance activities.

Clinical content, research selection, scoring frameworks, multilingual interpretation principles, safeguards, and final product decisions were reviewed and directed by the developer. The current analyzer does not use a generative AI model to independently diagnose a communication disorder or determine eligibility for services. Automated findings are intended to support clinician review and must be interpreted by a qualified speech-language pathologist.

Methodology — What the Analyzer Does

The analyzer separates measurement from clinical interpretation. Automated outputs are candidate findings until the clinician reviews and verifies the relevant coding.

  1. Preserve the original de-identified transcript.
  2. Identify mazes, repetitions, repairs, filled pauses, and unintelligible material.
  3. Propose C-unit segmentation using syntactic structure rather than transcript lines or punctuation.
  4. Require clinician review of C-unit boundaries and allow split, merge, restore, exclusion, and unscorable decisions.
  5. Calculate word-based measures from finalized units: MLUw = countable words ÷ eligible C-units; NDW = number of different word forms.
  6. Determine clinician-reviewed grammaticality and calculate PGU = grammatical PGU-eligible C-units ÷ scorable PGU-eligible C-units × 100.
  7. Use clinician-coded error counts for EPC = coded errors ÷ eligible C-units.
  8. Use separately reviewed clause counts for SI = eligible clauses ÷ eligible C-units. C-unit segmentation and clause counting are not interchangeable.
  9. Keep code-switching and possible cross-linguistic influence as separate annotations rather than automatic grammatical errors.
  10. Allow manual clinician scoring of narrative macrostructure/NSS when an appropriate source scoring guide and narrative protocol are used.
  11. Integrate language history, exposure, dialect/variety, dynamic assessment, caregiver/teacher information, functional impact, and other assessment evidence before clinical conclusions are made.
Core principle: Transcript line ≠ sentence ≠ C-unit. Ambiguity should remain visible for clinician review rather than being silently resolved.

Evidence & References

Important: Research citations identify empirical sources informing individual measures, coding procedures, or interpretation frameworks. Citation of a study does not indicate that the Multilingual Language Sample Analyzer itself has been validated or endorsed by the authors of that study.

PGU methodology: Guo, L.-Y., Eisenberg, S., Schneider, P., & Spencer, L. (2019). Percent Grammatical Utterances Between 4 and 9 Years of Age for the Edmonton Narrative Norms Instrument: Reference Data and Psychometric Properties. American Journal of Speech-Language Pathology, 28, 1448–1462. DOI

Spanish–English PGU/MLUw: Hernandez, M., Ronderos, J., & Castilla-Earls, A. P. (2024). Diagnostic Accuracy of Grammaticality and Utterance Length in Bilingual Children. Language, Speech, and Hearing Services in Schools, 55, 577–597. DOI

Exposure-aware English LSA: Ramos, M. N., Bedore, L. M., & Peña, E. D. (2026). The Diagnostic Value of English Language Sample Measures for Identifying Developmental Language Disorder in Bilingual Children. American Journal of Speech-Language Pathology, 35, 952–968. DOI

English tense/agreement: Ronderos, J., & Castilla-Earls, A. (2026). What Can English Tell Us? English Tense/Agreement Measures as Tools for Identification of Spanish–English Bilingual Children With Developmental Language Disorder. American Journal of Speech-Language Pathology, 35, 884–900. DOI

Bilingual LSA diagnostic evidence: Ortiz, J. A., Chow, J. C., Nolasco, J. M., & Huang, Y. T. (2026). Language Sample Analysis in Bilingual Children: A Meta-Analysis of Diagnostic Accuracy. American Journal of Speech-Language Pathology, 35, 1304–1321. DOI

Spanish grammatical forms / MLU context: Baron, A., Bedore, L. M., Peña, E. D., Lovgren-Uribe, S. D., López, A. A., & Villagrana, E. (2018). Production of Spanish Grammatical Forms in U.S. Bilingual Children. DOI

The detailed Evidence & References workspace also displays rule-level evidence metadata and validation tools after a sample is analyzed.